LFVN today
$4.88-$0.16 (-3.17%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bullish
1 hourStrong Bullish
15 minStrong Bearish
5 minStrong Bullish
Daily trend turns down below $3.90
Key levels
Resistance$5.53
Resistance$5.05
Support$4.55
Support$3.90
Latest news & SEC filings
EarningsLifeVantage Corporation Reports First Quarter Fiscal 2027 Financial Results
NewsLifeVantage Board Approves Payout to Shareholders
EarningsLifevantage Q1 adjusted EPS $0.05, sales $37.117M, both below estimates
All LFVN news →About LifeVantage
LifeVantage is a direct-selling company centered on nutrigenomics. It sells dietary supplements, weight-management aids, digestive-support items, skincare and haircare lines, and nootropic drink mixes under brands such as Protandim, TrueScience, P84 System, Petandim, and AXIO. Its buyers and sales-force members are spread across North America, Asia, Europe, and Oceania.
Based on the company's 10-K filed Aug 27, 2026.
Nasdaq · Healthcare
Lifevantage Corp (LFVN)
What Is the Price Target for LFVN?
SEPT Low Target
$6.00
SEPT Mid Target
$6.00
SEPT High Target
$6.00
Analyst Consensus
$6.00
Is LFVN a Buy or Sell Right Now?
Thesis
- •Revenue growing -20.1% YoY with DECLINING trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LFVN.
Start Free Trial →Is LFVN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$6.36
43
Moat Score
NARROW
6/9
Piotroski Score
2.6
Altman Z-Score
What Is Smart Money Doing with LFVN?
Insider Signal
BUYING
4 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Cunningham Kristen | officer | Buy | 32,850 | - | Oct 7, 2026 |
| Aure Carl | officer | Buy | 35,749 | - | Oct 7, 2026 |
| Moorehead Terrence | director officer | Buy | 193,237 | - | Oct 7, 2026 |
| Aure Carl | officer | Sale | 460 | $3K | Oct 1, 2026 |
| Cunningham Kristen | officer | Sale | 637 | $4K | Oct 1, 2026 |
| BEINDORFF MICHAEL A | director | Sale | 10,000 | $85K | Jun 3, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LFVN Growth Story
Revenue YoY
-20.1%
3yr Revenue CAGR
-5.1%
EPS Growth YoY
-46.67%
FCF Growth YoY
-36.5%
Revenue Trend
DECLINING
Dark Pool Trades for LFVN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LFVN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:14:45 | $4.88 | 1,000 | $$5K | MIDPOINT |
| 19:14:42 | $4.76 | 2,000 | $$10K | SELL |
| 19:14:04 | $4.88 | 1,000 | $$5K | MIDPOINT |
| 19:14:03 | $4.88 | 1,000 | $$5K | BUY |
| 19:14:01 | $4.76 | 2,000 | $$10K | SELL |
5 dark pool trades shown · $$34K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Lifevantage Corp (LFVN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LFVN — frequently asked questions
What is LFVN stock price today?
Lifevantage Corp (LFVN) is at $4.88, down 3.17% (-$0.16) at the Nov 13, 2026 close.
Why is LFVN stock moving today?
Latest LFVN news — Nov 10, 2026: LifeVantage Corporation Reports First Quarter Fiscal 2027 Financial Results · Nov 10, 2026: LifeVantage Board Approves Payout to Shareholders
What is the LFVN price target?
The average analyst price target for LFVN is $6.00, ranging from $6 to $6, based on 1 analysts. Latest: Lake Street maintains on Aug 28, 2026.
What do analysts rate LFVN?
Analyst ratings for LFVN: 0 Buy, 1 Hold, 1 Sell — consensus Hold.
Did LFVN beat earnings?
LFVN last reported on Aug 27, 2026: EPS $0.11 vs $0.12 expected — a miss of 4.3%.
What is LFVN's P/E ratio?
LFVN trades at a P/E of 13.5 vs a Healthcare average of 17.3.
Does LFVN pay a dividend?
Yes. LFVN's dividend yield is 1.29%.
What are LFVN support and resistance levels?
Support: $4.55, $3.90, $3.08. Resistance: $5.05, $5.53, $6.03.
What are insiders doing with LFVN?
Insider activity: BUYING, 4 buys and 1 sells in the last 90 days.
What is the latest news on LFVN?
Nov 10, 2026: LifeVantage Corporation Reports First Quarter Fiscal 2027 Financial Results · Nov 10, 2026: LifeVantage Board Approves Payout to Shareholders · Nov 9, 2026: Lifevantage Q1 adjusted EPS $0.05, sales $37.117M, both below estimates